Few comments from Platypus AM from their latest monthly report for March
"Turnover was a touch over 11% in March as we initiated new positions in Acrux and IOOF Holdings, and bought back Myer and ALS Ltd. Acrux has licensed their testosterone product to Eli Lily, which is once again starting to take market share from incumbent treatments."
http://www.platypusassetmanagement.com.au/performance/performance.html
- Forums
- ASX - By Stock
- ACR
- eli lilly
ACR
acrux limited
Add to My Watchlist
5.56%
!
1.7¢

eli lilly , page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.7¢ |
Change
-0.001(5.56%) |
Mkt cap ! $6.931M |
Open | High | Low | Value | Volume |
1.8¢ | 1.9¢ | 1.7¢ | $8.809K | 495.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 82249 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 213011 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32249 | 0.017 |
1 | 218000 | 0.016 |
2 | 266732 | 0.015 |
1 | 70000 | 0.014 |
2 | 397000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 616161 | 2 |
0.019 | 697115 | 4 |
0.020 | 670000 | 3 |
0.021 | 203466 | 1 |
0.022 | 118000 | 2 |
Last trade - 14.49pm 24/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |